Clinical Trial Update: Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial evaluating the safety and microbiome impact of intravesical Lactobacillus crispatus in spinal cord injury–related neurogenic bla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Spinal Cord Injury
• Urinary Tract Infection

Drugs mentioned

• Lactobacillus crispatus (Lactobacillus crispatus)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Spinal Cord Injuries (SCI), Neurogenic Bladder | EARLY_Phase 1 | Status: RECRUITING